Vytorin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
<applet load="" size="430" color="" frame="true" spin="on" Scene ="75/757901/3d_structure_of_vytorin/1" align="right" caption="Ezetimibe and Simvastatin come together to make up the medication | <applet load="" size="430" color="" frame="true" spin="on" Scene ="75/757901/3d_structure_of_vytorin/1" align="right" caption="Ezetimibe and Simvastatin come together to make up the medication known as Vytorin"/> | ||
==Vytorin (ezetimibe & simvastatin)== | ==Vytorin (ezetimibe & simvastatin)== | ||
Vytorin is a brand name drug used to treat Dyslipidemia, an abnormal amount of cholesterol or other lipids in the blood. It is composed of two separate medications, Simvastatin (generic for Zocor) and Ezetimibe (generic for Zetia). Ezetimibe works by decreasing cholesterol absorption in the small intestine. The second component of Vytorin, Simvastatin, works by reducing the production of cholesterol. | '''Vytorin''' is a brand name drug used to treat Dyslipidemia, an abnormal amount of cholesterol or other lipids in the blood. It is composed of two separate medications, Simvastatin (generic for Zocor) and Ezetimibe (generic for Zetia). Ezetimibe works by decreasing cholesterol absorption in the small intestine. The second component of Vytorin, Simvastatin, works by reducing the production of cholesterol. | ||
== Pharmacodynamics == | == Pharmacodynamics == |